Evidence-Based Medicine Guidelines
Dopamine agonists for preventing ovarian hyperstimulation syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dopamine Agonists for Preventing Ovarian Hyperstimulation Syndrome." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305077/all/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome.
Dopamine agonists for preventing ovarian hyperstimulation syndrome. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305077/all/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome. Accessed March 10, 2025.
Dopamine agonists for preventing ovarian hyperstimulation syndrome. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305077/all/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome
Dopamine Agonists for Preventing Ovarian Hyperstimulation Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305077/all/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dopamine agonists for preventing ovarian hyperstimulation syndrome
ID - 1305077
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305077/all/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
